BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8492451)

  • 1. [The trend of molecular biology study on eosinophils].
    Yamaguchi Y
    Nihon Rinsho; 1993 Mar; 51(3):741-6. PubMed ID: 8492451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eosinophil major basic protein induces degranulation and IL-8 production by human eosinophils.
    Kita H; Abu-Ghazaleh RI; Sur S; Gleich GJ
    J Immunol; 1995 May; 154(9):4749-58. PubMed ID: 7722326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eosinophil cationic protein cDNA. Comparison with other toxic cationic proteins and ribonucleases.
    Barker RL; Loegering DA; Ten RM; Hamann KJ; Pease LR; Gleich GJ
    J Immunol; 1989 Aug; 143(3):952-5. PubMed ID: 2745977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of transcription in eosinophils: GATA-1, but not GATA-2, transactivates the promoter of the eosinophil granule major basic protein gene.
    Yamaguchi Y; Ackerman SJ; Minegishi N; Takiguchi M; Yamamoto M; Suda T
    Blood; 1998 May; 91(9):3447-58. PubMed ID: 9558404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased expression of eosinophil peroxidase and major basic protein messenger RNAs during eosinophil maturation.
    Gruart V; Truong MJ; Plumas J; Zandecki M; Kusnierz JP; Prin L; Vinatier D; Capron A; Capron M
    Blood; 1992 May; 79(10):2592-7. PubMed ID: 1375105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokine induction of granule protein synthesis in an eosinophil-inducible human myeloid cell line, AML14.
    Paul CC; Ackerman SJ; Mahrer S; Tolbert M; Dvorak AM; Baumann MA
    J Leukoc Biol; 1994 Jul; 56(1):74-9. PubMed ID: 8027673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C/EBPbeta and GATA-1 synergistically regulate activity of the eosinophil granule major basic protein promoter: implication for C/EBPbeta activity in eosinophil gene expression.
    Yamaguchi Y; Nishio H; Kishi K; Ackerman SJ; Suda T
    Blood; 1999 Aug; 94(4):1429-39. PubMed ID: 10438731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Biochemistry and biological activities of eosinophil granule proteins].
    Enokihara H; Koike T
    Nihon Rinsho; 1993 Mar; 51(3):605-12. PubMed ID: 7684096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel combinatorial interactions of GATA-1, PU.1, and C/EBPepsilon isoforms regulate transcription of the gene encoding eosinophil granule major basic protein.
    Du J; Stankiewicz MJ; Liu Y; Xi Q; Schmitz JE; Lekstrom-Himes JA; Ackerman SJ
    J Biol Chem; 2002 Nov; 277(45):43481-94. PubMed ID: 12202480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro killing of microfilariae of Brugia pahangi and Brugia malayi by eosinophil granule proteins.
    Hamann KJ; Gleich GJ; Checkel JL; Loegering DA; McCall JW; Barker RL
    J Immunol; 1990 Apr; 144(8):3166-73. PubMed ID: 2324497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Release of granule proteins from eosinophils cultured with IL-5.
    Kita H; Weiler DA; Abu-Ghazaleh R; Sanderson CJ; Gleich GJ
    J Immunol; 1992 Jul; 149(2):629-35. PubMed ID: 1624806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The molecular biology of eosinophil granule proteins.
    Hamann KJ; Barker RL; Ten RM; Gleich GJ
    Int Arch Allergy Appl Immunol; 1991; 94(1-4):202-9. PubMed ID: 1657792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of neutrophil and eosinophil secondary granule gene expression by transcription factors C/EBP epsilon and PU.1.
    Gombart AF; Kwok SH; Anderson KL; Yamaguchi Y; Torbett BE; Koeffler HP
    Blood; 2003 Apr; 101(8):3265-73. PubMed ID: 12515729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Eosinophil granule proteins (MBP, ECP, EPX/EDN, EPO)--a possible process of eosinophil activation and degranulation].
    Tsuda S; Miyasato M
    Nihon Rinsho; 1993 Mar; 51(3):613-9. PubMed ID: 8492433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deletion of the major GATA1 enhancer HS 1 does not affect eosinophil GATA1 expression and eosinophil differentiation.
    Guyot B; Valverde-Garduno V; Porcher C; Vyas P
    Blood; 2004 Jul; 104(1):89-91. PubMed ID: 15016648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinctive cationic proteins of the human eosinophil granule: major basic protein, eosinophil cationic protein, and eosinophil-derived neurotoxin.
    Ackerman SJ; Loegering DA; Venge P; Olsson I; Harley JB; Fauci AS; Gleich GJ
    J Immunol; 1983 Dec; 131(6):2977-82. PubMed ID: 6644025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracellular deposition of eosinophil and neutrophil granule proteins in the IgE-mediated cutaneous late phase reaction.
    Leiferman KM; Fujisawa T; Gray BH; Gleich GJ
    Lab Invest; 1990 May; 62(5):579-89. PubMed ID: 2188046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mechanisms of eosinophil development].
    Yamaguchi Y
    Tanpakushitsu Kakusan Koso; 1998 Dec; 43(15):2161-71. PubMed ID: 9868352
    [No Abstract]   [Full Text] [Related]  

  • 19. Targeted deletion of a high-affinity GATA-binding site in the GATA-1 promoter leads to selective loss of the eosinophil lineage in vivo.
    Yu C; Cantor AB; Yang H; Browne C; Wells RA; Fujiwara Y; Orkin SH
    J Exp Med; 2002 Jun; 195(11):1387-95. PubMed ID: 12045237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative toxicity of purified human eosinophil granule proteins for newborn larvae of Trichinella spiralis.
    Hamann KJ; Barker RL; Loegering DA; Gleich GJ
    J Parasitol; 1987 Jun; 73(3):523-9. PubMed ID: 3598802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.